Return on Assets (ROA)
since 2005
Calculation
Abbott Laboratories, ROA, long-term trends, calculation
| ROA | = | 100 | × | Net earnings1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 16.46% | = | 100 | × | 13,402) | ÷ | 81,414) |
| Dec 31, 2023 | 7.82% | = | 100 | × | 5,723) | ÷ | 73,214) |
| Dec 31, 2022 | 9.31% | = | 100 | × | 6,933) | ÷ | 74,438) |
| Dec 31, 2021 | 9.40% | = | 100 | × | 7,071) | ÷ | 75,196) |
| Dec 31, 2020 | 6.20% | = | 100 | × | 4,495) | ÷ | 72,548) |
| Dec 31, 2019 | 5.43% | = | 100 | × | 3,687) | ÷ | 67,887) |
| Dec 31, 2018 | 3.53% | = | 100 | × | 2,368) | ÷ | 67,173) |
| Dec 31, 2017 | 0.63% | = | 100 | × | 477) | ÷ | 76,250) |
| Dec 31, 2016 | 2.66% | = | 100 | × | 1,400) | ÷ | 52,666) |
| Dec 31, 2015 | 10.72% | = | 100 | × | 4,423) | ÷ | 41,247) |
| Dec 31, 2014 | 5.53% | = | 100 | × | 2,284) | ÷ | 41,275) |
| Dec 31, 2013 | 6.00% | = | 100 | × | 2,576) | ÷ | 42,953) |
| Dec 31, 2012 | 8.87% | = | 100 | × | 5,963) | ÷ | 67,235) |
| Dec 31, 2011 | 7.84% | = | 100 | × | 4,728) | ÷ | 60,277) |
| Dec 31, 2010 | 7.78% | = | 100 | × | 4,626) | ÷ | 59,462) |
| Dec 31, 2009 | 10.96% | = | 100 | × | 5,746) | ÷ | 52,417) |
| Dec 31, 2008 | 11.51% | = | 100 | × | 4,881) | ÷ | 42,419) |
| Dec 31, 2007 | 9.08% | = | 100 | × | 3,606) | ÷ | 39,714) |
| Dec 31, 2006 | 4.75% | = | 100 | × | 1,717) | ÷ | 36,178) |
| Dec 31, 2005 | 11.57% | = | 100 | × | 3,372) | ÷ | 29,141) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
The financial data reveal a fluctuating pattern in the net earnings and total assets over the observed periods, coupled with varying returns on assets (ROA). Initially, net earnings showed a strong level with 3,372 million US dollars in 2005, followed by a significant decline to 1,717 million in 2006. Subsequently, net earnings experienced a general upward trend with some volatility, peaking at 7,071 million in 2021 before decreasing slightly in 2022, and then rising sharply to 13,402 million by 2024.
Total assets expanded considerably from 29,141 million in 2005 to a peak of 67,250 million in 2017, indicative of substantial asset accumulation. However, after 2017, total assets demonstrated some variability, declining to 74,438 million in 2022 before increasing again to 81,414 million in 2024, reflecting ongoing asset growth but at a variable rate.
Return on assets (ROA) exhibited a non-linear trend, starting with a robust 11.57% in 2005, followed by a decline to as low as 0.63% in 2017. After reaching this low point, ROA gradually improved, reaching a high of 16.46% in 2024, the highest in the dataset. This suggests an enhancement in asset utilization efficiency in the most recent years despite past fluctuations.
- Net earnings
- Showed volatility with a trough in 2006 and 2016-2017, contrasted by strong growth in 2021 and a peak in 2024.
- Total assets
- Generally increased over the period with notable growth until 2017; post-2017 data reveals fluctuations but an overall positive trend.
- Return on assets (ROA)
- Declined sharply to low levels around 2016-2017, then steadily improved to the highest level in 2024, indicating improved asset efficiency.
Overall, the data suggest a company experiencing periods of variable profitability and asset growth, with recent years marked by improved financial performance and asset management effectiveness as reflected in the ROA metric.
Comparison to Competitors
Abbott Laboratories, ROA, long-term trends, comparison to competitors
| Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2024 | 16.46% | 1.82% | 5.12% | 12.39% | 4.09% | 4.83% |
| Dec 31, 2023 | 7.82% | 3.34% | 5.50% | 11.64% | 4.13% | 8.18% |
| Dec 31, 2022 | 9.31% | 1.82% | 5.86% | 10.19% | 5.54% | 8.19% |
| Dec 31, 2021 | 9.40% | 3.39% | 6.26% | 12.58% | 3.87% | 8.15% |
| Dec 31, 2020 | 6.20% | 3.11% | 5.28% | 9.50% | 5.28% | 7.81% |
| Dec 31, 2019 | 5.43% | 2.98% | 6.21% | 14.17% | 5.16% | 7.96% |
| Dec 31, 2018 | 3.53% | -0.30% | 5.24% | 14.37% | 3.40% | 7.87% |
| Dec 31, 2017 | 0.63% | 6.96% | 5.45% | 11.46% | 4.04% | 7.59% |
| Dec 31, 2016 | 2.66% | 5.63% | 3.79% | 11.34% | 3.55% | 5.71% |
| Dec 31, 2015 | 10.72% | 5.59% | 4.15% | 12.00% | 2.51% | 5.22% |
| Dec 31, 2014 | 5.53% | 6.25% | 4.14% | 10.58% | 8.08% | 6.50% |
| Dec 31, 2013 | 6.00% | 6.42% | 4.18% | 16.99% | 9.95% | 6.87% |
| Dec 31, 2012 | 8.87% | 5.88% | 4.50% | 16.18% | 10.93% | 6.83% |
| Dec 31, 2011 | 7.84% | 5.36% | 5.09% | 16.16% | 10.18% | 7.57% |
| Dec 31, 2010 | 7.78% | 5.51% | 5.75% | 15.97% | 11.03% | 7.35% |
| Dec 31, 2009 | 10.96% | 6.00% | 9.10% | 12.85% | 9.17% | 6.47% |
| Dec 31, 2008 | 11.51% | 5.27% | 5.15% | 13.86% | 10.05% | 5.33% |
| Dec 31, 2007 | 9.08% | 4.82% | 6.43% | 13.90% | 14.36% | 9.14% |
| Dec 31, 2006 | 4.75% | 6.65% | 5.98% | 10.72% | 12.95% | 8.61% |
| Dec 31, 2005 | 11.57% | 8.01% | 4.79% | 18.77% | 10.86% | 7.98% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Abbott Laboratories, ROA, long-term trends, comparison to sector (health care equipment & services)
| Abbott Laboratories | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2024 | 16.46% | 5.17% |
| Dec 31, 2023 | 7.82% | 5.91% |
| Dec 31, 2022 | 9.31% | 5.77% |
| Dec 31, 2021 | 9.40% | 6.03% |
| Dec 31, 2020 | 6.20% | 5.44% |
| Dec 31, 2019 | 5.43% | 5.46% |
| Dec 31, 2018 | 3.53% | 3.71% |
| Dec 31, 2017 | 0.63% | 5.38% |
| Dec 31, 2016 | 2.66% | 4.64% |
| Dec 31, 2015 | 10.72% | 5.08% |
| Dec 31, 2014 | 5.53% | 6.08% |
| Dec 31, 2013 | 6.00% | 6.59% |
| Dec 31, 2012 | 8.87% | 7.19% |
| Dec 31, 2011 | 7.84% | 7.03% |
| Dec 31, 2010 | 7.78% | 7.18% |
| Dec 31, 2009 | 10.96% | 8.14% |
| Dec 31, 2008 | 11.51% | 6.92% |
| Dec 31, 2007 | 9.08% | 7.89% |
| Dec 31, 2006 | 4.75% | 7.31% |
| Dec 31, 2005 | 11.57% | 7.94% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Abbott Laboratories, ROA, long-term trends, comparison to industry (health care)
| Abbott Laboratories | Health Care | |
|---|---|---|
| Dec 31, 2024 | 16.46% | 5.25% |
| Dec 31, 2023 | 7.82% | 6.71% |
| Dec 31, 2022 | 9.31% | 8.71% |
| Dec 31, 2021 | 9.40% | 8.70% |
| Dec 31, 2020 | 6.20% | 5.45% |
| Dec 31, 2019 | 5.43% | 7.57% |
| Dec 31, 2018 | 3.53% | 6.72% |
| Dec 31, 2017 | 0.63% | 5.31% |
| Dec 31, 2016 | 2.66% | 7.18% |
| Dec 31, 2015 | 10.72% | 7.54% |
| Dec 31, 2014 | 5.53% | 8.41% |
| Dec 31, 2013 | 6.00% | 8.58% |
| Dec 31, 2012 | 8.87% | 7.94% |
| Dec 31, 2011 | 7.84% | 7.22% |
| Dec 31, 2010 | 7.78% | 7.11% |
| Dec 31, 2009 | 10.96% | 9.45% |
| Dec 31, 2008 | 11.51% | 9.08% |
| Dec 31, 2007 | 9.08% | 8.51% |
| Dec 31, 2006 | 4.75% | 10.37% |
| Dec 31, 2005 | 11.57% | 9.62% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).